Compugroup Medical (Germany) Performance
| COP Stock | EUR 25.00 0.02 0.08% |
Compugroup Medical has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.0425, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Compugroup Medical are expected to decrease at a much lower rate. During the bear market, Compugroup Medical is likely to outperform the market. Compugroup Medical right now shows a risk of 1.23%. Please confirm Compugroup Medical standard deviation, treynor ratio, downside variance, as well as the relationship between the total risk alpha and value at risk , to decide if Compugroup Medical will be following its price patterns.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Compugroup Medical SE are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Compugroup Medical is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 75.9 M | |
| Free Cash Flow | 87.8 M |
Compugroup |
Compugroup Medical Relative Risk vs. Return Landscape
If you would invest 2,380 in Compugroup Medical SE on September 26, 2025 and sell it today you would earn a total of 120.00 from holding Compugroup Medical SE or generate 5.04% return on investment over 90 days. Compugroup Medical SE is generating 0.0843% of daily returns assuming 1.2267% volatility of returns over the 90 days investment horizon. Simply put, 11% of all stocks have less volatile historical return distribution than Compugroup Medical, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Compugroup Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Compugroup Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Compugroup Medical SE, and traders can use it to determine the average amount a Compugroup Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0687
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | COP | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.23 actual daily | 11 89% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Compugroup Medical is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Compugroup Medical by adding it to a well-diversified portfolio.
Compugroup Medical Fundamentals Growth
Compugroup Stock prices reflect investors' perceptions of the future prospects and financial health of Compugroup Medical, and Compugroup Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Compugroup Stock performance.
| Current Valuation | 2.74 B | |||
| Price To Book | 2.94 X | |||
| Price To Sales | 1.82 X | |||
| Revenue | 1.03 B | |||
| EBITDA | 213.99 M | |||
| Total Debt | 587.08 M | |||
| Cash Flow From Operations | 165.27 M | |||
| Total Asset | 1.79 B | |||
About Compugroup Medical Performance
By examining Compugroup Medical's fundamental ratios, stakeholders can obtain critical insights into Compugroup Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Compugroup Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Compugroup Medical performance evaluation
Checking the ongoing alerts about Compugroup Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Compugroup Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Compugroup Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Compugroup Medical's stock performance include:- Analyzing Compugroup Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Compugroup Medical's stock is overvalued or undervalued compared to its peers.
- Examining Compugroup Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Compugroup Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Compugroup Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Compugroup Medical's stock. These opinions can provide insight into Compugroup Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Compugroup Stock
Compugroup Medical financial ratios help investors to determine whether Compugroup Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Compugroup with respect to the benefits of owning Compugroup Medical security.